Scripps' Board Approves "Poison Pill" in Response to Sinclair's Buyout Offer.

miércoles, 26 de noviembre de 2025, 10:19 am ET1 min de lectura
SBGI--
SSP--

Scripps' board approves 'poison pill' after Sinclair's buyout offer at $7 per share. The move aims to prevent Sinclair from acquiring the company without paying a higher price. Scripps will now issue shareholder rights to existing investors, allowing them to buy additional shares at a discounted price if Sinclair acquires more than 10% of the company's shares.

Scripps' Board Approves "Poison Pill" in Response to Sinclair's Buyout Offer.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios